Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome-Reference-Cited by-同舟云学术

Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome

Published:2021 Issue: Volume:19 Page:4435-4446
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Dong Qi,Liu Mingyue,Chen Bo,Zhao Zhangxiang,Chen Tingting,Wang Chengyu,Zhuang Shuping,Li Yawei,Wang Yuquan,Ai Liqiang,Liu Yaoyao,Liang Haihai,Qi Lishuang,Gu Yunyan

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference40 articles.

1. PARP and PARG inhibitors in cancer treatment;Slade;Genes Dev,2020

2. The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a review;Patel;Cell Biosci,2020

3. PARP inhibitor resistance: the underlying mechanisms and clinical implications;Li;Mol Cancer,2020

4. Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer;Konstantinopoulos;Cancer Discov,2015

5. Mapping genetic interactions in cancer: a road to rational combination therapies;Tutuncuoglu;Genome Med,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway;JCI Insight;2023-11-08

2. Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells;British Journal of Cancer;2023-08-24

3. Lactate gene signature based on mitophagy predict the prognosis and immune response in lung adenocarcinoma;2023-07-17

4. Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review);International Journal of Oncology;2023-01-04